India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working with the activist investor

Two former Pfizer executives said they will not be involved with activist investor Starboard Value

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

Opinion: An upcoming FDA ad comm on a treatment for the ultra rare Barth syndrome can’t use the normal measuring sticks for success.

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes and obesity drug from a shortages list

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes

We generally don’t think of rare-disease advocacy as funny. But Sammy Basso, who died at 28, will be remembered for his ability to find laughter in almost anything.

Chinese drugmakers targeted by forthcoming U.S. national security legislation are working on sales of some operations

A major California health insurer is set to offer one of the world’s top-selling drugs for free in a bid to show it can reach Americans affordably

CVS Health is exploring options that could include a breakup of the company to separate its retail and insurance units

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online meetings and phone calls…

Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the Alzheimer's drug simufilam, and agreed to pay fines.

The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers who fell ill after caring for the patient.

Despite no known infections of H5N1 bird flu among its dairy cows, Missouri recently detected a case in a person with no apparent exposure to possibly infected animals or related products (i.e., raw milk). A close contact and two health workers who c

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.

Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who

Novo Nordisk CEO Lars Fruergaard Jørgensen will testify at a Senate hearing today about the prices of Ozempic and Wegovy. Here's what to expect.

As remote patient monitoring use jumps, federal watchdog sees potential for Medicare overpayments.

A dark-money group has launched a multi-state bus tour to bring awareness to what it characterizes as bad behavior by pharma.

A price battle has broken out in the hot market for weight loss drugs, with drugmakers dangling discounts.

A U.S. House committee passed a bill to renew a program to aid development of drugs for rare diseases in children.

Some drugmakers' submission of multiple "use codes" to expand patent claims appears to be delaying the arrival of lower-cost generics.

Express Scripts lawsuit demands the FTC vacate a report accusing PBMs of raising drug prices, calling it "unsupported innuendo."

An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of muscle-invasive tumors.